Skip to main content

Erelzi News

Updated FDA Labeling Recommendations for Biosimilar and Interchangeable Biosimilar Products

October 26, 2023 – Over the last eight years, FDA has approved more than 40 biosimilar products (biosimilars), and they have become an important treatment option for health care professionals and...

FDA Approves Erelzi (etanercept-szzs), a Biosimilar to Enbrel

August 30, 2016 – The U.S. Food and Drug Administration today approved Erelzi, (etanercept-szzs) for multiple inflammatory diseases. Erelzi is a biosimilar to Enbrel (etanercept), which was...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis, Juvenile Rheumatoid Arthritis, Plaque Psoriasis

Erelzi patient information at Drugs.com